Enhancement of Cancer Research at Clark Atlanta University
克拉克亚特兰大大学癌症研究的加强
基本信息
- 批准号:10376107
- 负责人:
- 金额:$ 11.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-06-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AffectAfrican AmericanAgeAnimal ExperimentationAreaAwarenessBasic ScienceBehavioralBiologicalBiological SciencesCaliberCancer BiologyCaucasiansCellular biologyChemistryCommunitiesCommunity OutreachCore FacilityDevelopmentDiseaseEarly DiagnosisEarly treatmentEducationEducational ActivitiesEquipmentFacultyFaculty RecruitmentFundingFuture GenerationsIncidenceInformation DisseminationInfrastructureInstitutionInternationalLaboratoriesLaboratory ResearchMalignant NeoplasmsMalignant neoplasm of prostateMentorsMissionModernizationMolecularMolecular BiologyMolecular and Cellular BiologyNCI Center for Cancer ResearchPilot ProjectsPostdoctoral FellowPreventionPrivatizationProgram DevelopmentProstate Cancer therapyResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingRiskSchoolsScientistStudentsTeacher Professional DevelopmentTherapeuticTimeTrainingTraining and EducationUnited States National Institutes of HealthUniversitiesadvanced diseaseanticancer researchbasebiological researchcancer cellcancer therapycertificate programcohesioncombatcommunity based researchcommunity engagementdrug discoverygraduate studenthigher educationinfrastructure developmentinterestmembermenmortalitynext generationoutreach programprogram disseminationprogramsprostate cancer progressionracial and ethnicracial diversityrecruitresearch and developmentsocioeconomicstenure tracktherapeutic developmentundergraduate student
项目摘要
Summary
Clark Atlanta University (CAU) is a comprehensive, private, urban, coeducational institution of higher education
with a predominantly African-American heritage. It offers undergraduate, graduate, and professional degrees as
well as certificate programs to students of diverse racial, ethnic, and socioeconomic backgrounds. The Center
for Cancer Research and Therapeutic Development (CCRTD) was established at CAU in 1999 with direct
support from the NIH/RCMI program. CCRTD faculty was derived from the Departments of Biological Sciences,
Chemistry and School of Education with research interests in cancer biology, drug discovery and behavioral
aspects of cancer. In 2004, we decided to build a comprehensive research and educational program which will
focus on prostate cancer and its impact in the African-American community. In 2005, the Center was designated
as CAU's University-wide Center of Excellence to a) develop a core group of internationally known scientists,
that will carry-out highly productive basic research in cancer cell biology and molecular biology and contribute in
the development of successful therapeutic strategies to combat cancer., b) train undergraduate and graduate
students and post-doctoral fellows in the area of cancer biology and, hence, help develop the future generation
of African-American scientists of the highest caliber. And c) establish an educational program to increase
awareness for prevention, early detection and treatment of cancers, especially those which disproportionately
affect the African-American community. As a consequence of targeted recruitment of faculty and staff over the
past 12 years, CCRTD is currently one of the largest centers of its kind in the nation with a unique and
comprehensive program to combat prostate cancer. We recruited 9 tenure-track faculty members with
established expertise in the area of cell and molecular biology of cancer. They established their research
programs at CCRTD which focus on understanding molecular mechanisms in the development and progression
of prostate cancer and also on the biological basis of higher incidence and development of more advanced
disease at an earlier age in African-American men. In order to provide state-of-the art research infrastructure to
carry out cutting-edge cell and molecular biology research, CCRTD has developed research core laboratories to
support research activities of faculty, staff and students. These core facilities have undergone significant
expansion throughout the past several years. We have also been actively engaged in the research training and
education of both undergraduate and graduate students in the area of prostate cancer biology. Our community
outreach has established dynamic educational and community based research programs which serve the
African-American community in the metro Atlanta and beyond. The current proposal seeks to expand and
enhance current research and educational activities at CCRTD and will focus on three specific aims. First aim
will expand and enhance current research programs in prostate cancer and professional development
by supporting three research projects and developing a pilot project program to support junior faculty,
investigators and postdoctoral scientists. The second aim will attempt to restructure and modernize research
core facilities by consolidating current 8 core research laboratories into 5 core laboratories to create a more
efficient research infrastructure. we will also establish a new animal research core laboratory acquire new
equipment to upgrade the current research core laboratories. The purpose of the aim 3 will be to create an
integrated infrastructure for development of a comprehensive program for dissemination of information and
community engagement which will involve local, national and global communities. We will use our current
strengths in professional development programs in basic research area, and in the community outreach and
educational programs to create this new infrastructure.
概括
克拉克亚特兰大大学(CAU)是一家全面的,私人的,城市的高等教育机构
拥有主要的非裔美国人遗产。它提供本科,研究生和专业学位
以及为各种种族,种族和社会经济背景的学生提供证书计划。中心
癌症研究和治疗发展(CCRTD)于1999年在CAU建立了直接
NIH/RCMI计划的支持。 CCRTD教师源自生物科学系,
化学和教育学院具有癌症生物学,药物发现和行为的研究兴趣
癌症的各个方面。 2004年,我们决定建立一个全面的研究和教育计划
专注于前列腺癌及其对非裔美国人社区的影响。 2005年,该中心被指定
作为CAU在大学范围内的卓越中心a)发展一个核心的国际知名科学家,
这将在癌细胞生物学和分子生物学方面进行高生产力的基础研究,并在
开发成功打击癌症的治疗策略。,b)培训本科生和毕业生
癌症生物学领域的学生和博士后研究员,因此有助于发展未来的一代
口径最高的非裔美国人科学家。 c)建立一个教育计划以增加
对预防,早期发现和治疗癌症的认识,尤其是那些不成比例的癌症
影响非裔美国人社区。由于有针对性地招募教职员工
过去的12年,CCRTD目前是全美最大的中心之一,拥有独特的和独特的
打击前列腺癌的综合计划。我们招募了9名任职教师
在细胞和癌症分子生物学领域建立了专业知识。他们建立了研究
CCRTD的计划,该程序着重于理解开发和发展中的分子机制
前列腺癌以及更高发病率和发展的生物学基础
非洲裔美国男性较早的疾病。为了提供最先进的研究基础设施
进行尖端细胞和分子生物学研究,CCRTD已开发了研究核心实验室
支持教职员工和学生的研究活动。这些核心设施已经发生了重大
在过去的几年中的扩张。我们还积极从事研究培训和
在前列腺癌生物学领域的本科生和研究生的教育。我们的社区
宣传已经建立了动态教育和社区研究计划,以服务于
亚特兰大大都会及其他地区的非裔美国人社区。当前的提案旨在扩大和
加强CCRTD的当前研究和教育活动,并将重点关注三个特定目标。第一个目标
将扩大和增强前列腺癌和专业发展的当前研究计划
通过支持三个研究项目并制定一项试点项目计划以支持初级教师
研究人员和博士后科学家。第二个目标将尝试重组和现代化研究
通过将当前8个核心研究实验室合并为5个核心实验室,以创建更多的核心设施
有效的研究基础设施。我们还将建立一个新的动物研究核心实验室将获得新的
升级当前研究核心实验室的设备。目标3的目的是创建一个
用于开发全面计划的综合基础架构,用于传播信息和
社区参与将涉及地方,国家和全球社区。我们将使用我们的电流
基础研究领域的专业发展计划的优势,社区推广和
教育计划,以创建这个新的基础架构。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAQING WU其他文献
DAQING WU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAQING WU', 18)}}的其他基金
Targeting chemoresistant prostate cancer with novel EED inhibitors
使用新型 EED 抑制剂靶向化疗耐药性前列腺癌
- 批准号:
10444602 - 财政年份:2022
- 资助金额:
$ 11.52万 - 项目类别:
Diversity Supplement: Targeting chemoresistant prostate cancer with novel EED inhibitors
多样性补充:用新型 EED 抑制剂靶向化疗耐药性前列腺癌
- 批准号:
10747516 - 财政年份:2022
- 资助金额:
$ 11.52万 - 项目类别:
Targeting chemoresistant prostate cancer with novel EED inhibitors
使用新型 EED 抑制剂靶向化疗耐药性前列腺癌
- 批准号:
10590661 - 财政年份:2022
- 资助金额:
$ 11.52万 - 项目类别:
Small-molecule therapy for metastatic castration-resistant prostate cancer
转移性去势抵抗性前列腺癌的小分子治疗
- 批准号:
10325729 - 财政年份:2017
- 资助金额:
$ 11.52万 - 项目类别:
Small-molecule therapy for metastatic castration-resistant prostate cancer
转移性去势抵抗性前列腺癌的小分子治疗
- 批准号:
10472020 - 财政年份:2017
- 资助金额:
$ 11.52万 - 项目类别:
Small-molecule therapy for metastatic prostate cancer
转移性前列腺癌的小分子治疗
- 批准号:
9407585 - 财政年份:2017
- 资助金额:
$ 11.52万 - 项目类别:
A Dietary Supplement As Adjunct Therapy In Castration-Resistant Prostate Cancer
膳食补充剂作为去势抵抗性前列腺癌的辅助治疗
- 批准号:
8834755 - 财政年份:2015
- 资助金额:
$ 11.52万 - 项目类别:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
EPLIN 作为金雀异黄素预防前列腺癌转移的分子靶点
- 批准号:
8854250 - 财政年份:2012
- 资助金额:
$ 11.52万 - 项目类别:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
EPLIN 作为金雀异黄素预防前列腺癌转移的分子靶点
- 批准号:
8507638 - 财政年份:2012
- 资助金额:
$ 11.52万 - 项目类别:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
EPLIN 作为金雀异黄素预防前列腺癌转移的分子靶点
- 批准号:
8386046 - 财政年份:2012
- 资助金额:
$ 11.52万 - 项目类别:
相似海外基金
Role of YB1 in health disparities in triple negative breast cancer
YB1 在三阴性乳腺癌健康差异中的作用
- 批准号:
10655943 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
加强药物管理以控制非裔美国人和拉丁裔的 ADRD 风险因素
- 批准号:
10610975 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
- 批准号:
10577022 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of School Segregation and Experiences of Discrimination
阿尔茨海默病和相关痴呆症的种族差异:学校隔离的作用和歧视经历
- 批准号:
10606362 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别: